SYNALAR

This brand name is authorized in Canada, Cyprus, Spain, Hong Kong, Mexico, United Kingdom, United States, South Africa

Active ingredients

The drug SYNALAR contains one active pharmaceutical ingredient (API):

1 Fluocinolone UNII 0CD5FD6S2M - FLUOCINOLONE ACETONIDE

Fluocinolone acetonide is a synthetic fluorinated corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Fluocinolone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07AC04	Fluocinolone acetonide	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02162512
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 37290, 39411, 44205, 46441, 49275
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 115073, 21569, 21586, 21589, 21604, 21620, 21647, 83885
Country: HK	Department of Health Drug Office	Identifier(s): 06809, 06829, 06832
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 55749
Country: US	FDA, National Drug Code	Identifier(s): 43538-900, 43538-910, 43538-920
Country: ZA	Health Products Regulatory Authority	Identifier(s): B/13.4.1/133